HIGH.F CANTOURAGE GROUP SE O.N.

Healthcare Pharmaceuticals Frankfurt Exchange
4.82 EUR
Close of Nov 12, 2026
2.13 6.80
Market cap
EUR 57.2M
P/E
-
P/B
1.18x
ROE
-10.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2023.

Is HIGH.F undervalued?

Graham number

The Graham number of CANTOURAGE GROUP SE O.N. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CANTOURAGE GROUP SE O.N. fundamental analysis

No fundamental analysis for CANTOURAGE GROUP SE O.N. yet.

CANTOURAGE GROUP SE O.N. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CANTOURAGE GROUP SE O.N.

Cantourage Group SE, a medical cannabis company, produces and distributes medical cannabis preparations and cannabis-based pharmaceuticals in Europe and internationally. The company offers cannabis dried flowers, extracts, dronabinol/tetrahydrocannabinol (THC), and cannabidiol (CBD) products. It exports its products to other European countries. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is h…

Full company profile